Don Henry is director of the Office of Program and Regulatory Operations in FDA’s Center for Drug Evaluation and Research’s Office of Pharmaceutical Quality.
High-Quality Communication Enables High-Quality Drug Products
User fee programs have improved FDA’s approval timeline for important therapies.